Blocking TLR2 Activity Attenuates Pulmonary Metastases of Tumor

• Hong-Zhen Yang ,

  Contributed equally to this work with: Hong-Zhen Yang, Bing Cui

  Affiliation Molecular Immunology and Pharmacology Laboratory, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

  ⨯
• Bing Cui ,

  Contributed equally to this work with: Hong-Zhen Yang, Bing Cui

  Affiliation Molecular Immunology and Pharmacology Laboratory, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

  ⨯
• Han-Zhi Liu,

  Affiliation Molecular Immunology and Pharmacology Laboratory, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

  ⨯
• Su Mi,

  Affiliation Molecular Immunology and Pharmacology Laboratory, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

  ⨯
• Jun Yan,

  Affiliation Molecular Immunology and Pharmacology Laboratory, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

  ⨯
• Hui-Min Yan,

  Affiliation Molecular Immunology and Pharmacology Laboratory, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

  ⨯
• Fang Hua,

  Affiliation Molecular Immunology and Pharmacology Laboratory, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

  ⨯
• Heng Lin,

  Affiliation Molecular Immunology and Pharmacology Laboratory, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

  ⨯
• Wen-Feng Cai,

  Affiliation Molecular Immunology and Pharmacology Laboratory, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

  ⨯
• Wen-Jie Xie,

  Affiliation Molecular Immunology and Pharmacology Laboratory, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

  ⨯
• Xiao-Xi Lv,

  Affiliation Molecular Immunology and Pharmacology Laboratory, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

  ⨯
• Xiao-Xing Wang,

  Affiliation Molecular Immunology and Pharmacology Laboratory, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

  ⨯
• Bing-Mu Xin,

  Affiliation Molecular Immunology and Pharmacology Laboratory, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

  ⨯
• Qi-Min Zhan,

  Affiliation State Key Laboratory of Molecular Oncology, Cancer Institute and Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

  ⨯
• Zhuo-Wei Hu

  * E-mail: huzhuowei@imm.ac.cn

  Affiliations Molecular Immunology and Pharmacology Laboratory, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, State Key Laboratory of Molecular Oncology, Cancer Institute and Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

  ⨯